Whither radioimmunotherapy: To be or not to be?

od Green, Damian J., Press, Oliver W.
Wydane w Cancer Res (2017)

A Prospective Study of Lenalidomide Monotherapy for Relapse After Allogeneic Stem Cell Transplant for Multiple Myeloma

od Bensinger, William I., Green, Damian J., Burwick, Nicholas, Becker, Pamela S
Wydane 2014

Chimeric Antigen Receptor T cells for Multiple Myeloma: The Journey So Far – And the Road Ahead

od Cowan, Andrew J., Tuazon, Sherilyn, Portuguese, Andrew J., Green, Damian J.
Wydane w Cancer J (2021)

Pulmonary Embolization of Fat and Bone Marrow in Cynomolgus Macaques (Macaca fascicularis)

od Fong, Derek L., Murnane, Robert D., Hotchkiss, Charlotte E., Green, Damian J., Hukkanen, Renee R.
Wydane 2011

Bortezomib and Fenretinide Induce Synergistic Cytotoxicity in Mantle Cell Lymphoma Via Apoptosis, Cell Cycle Dysregulation, and IκBα Kinase Down-regulation

od Cowan, Andrew J., Frayo, Shani L., Press, Oliver W., Palanca-Wessels, Maria C., Pagel, John M., Green, Damian J., Gopal, Ajay K.
Wydane w Anticancer Drugs (2015)

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect

od Maffini, Enrico, Anderson, Larry D., Sandmaier, Brenda M., Green, Damian J., Storer, Barry E., Niederwieser, Dietger, Maziarz, Richard T., Maloney, David G., Storb, Rainer
Wydane w Haematologica (2018)

Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma

od Coffey, David G., Wu, Qian V., Towlerton, Andrea M. H., Ornelas, Sharon, Morales, Alicia J., Xu, Yuexin, Green, Damian J., Warren, Edus H.
Wydane w Blood Cancer J (2019)

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma

od Greenbaum, Adam M., Green, Damian J., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Rasmussen, Heather, Press, Oliver W., Gopal, Ajay K.
Wydane w Blood Res (2018)

Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patie...

od Gopal, Ajay K., Tarantolo, Stefano R., Bellam, Naresh, Green, Damian J., Griffin, Melissa, Feldman, Tatyana, Mato, Anthony R., Eisenfeld, Amy J., Stromatt, Scott C., Goy, Andre
Wydane w Invest New Drugs (2014)

A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations

od Pagel, John M., Orgun, Nural, Hamlin, Donald K., Wilbur, D. Scott, Gooley, Theodore A., Gopal, Ajay K., Park, Steven I., Green, Damian J., Lin, Yukang, Press, Oliver W.
Wydane 2009

In vivo Localization of (90)Y- and (177)Lu-Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model

od Balkin, Ethan R., Kenoyer, Aimee, Orozco, Johnnie J., Hernandez, Alexandra, Shadman, Mazyar, Fisher, Darrell R., Green, Damian J., Hylarides, Mark D., Press, Oliver W., Wilbur, D. Scott, Pagel, John M.
Wydane 2014

Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous...

od Cowan, Andrew J., Klippel, Zandra K., Stevenson, Philip A., Hyun, Teresa S., Tuazon, Sherilyn, Becker, Pamela S., Green, Damian J., Holmberg, Leona A., Coffey, David G., Gopal, Ajay K., Libby, Edward N.
Wydane w Amyloid (2016)

Long-Term Follow Up of (90)Y-ibritumomab Tiuxetan, Fludarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B-Cell Lymphoma

od Puronen, Camille E., Cassaday, Ryan D., Stevenson, Philip A., Sandmaier, Brenda M., Flowers, Mary E., Green, Damian J., Maloney, David G., Storb, Rainer F., Press, Oliver W., Gopal, Ajay K.
Wydane w Biol Blood Marrow Transplant (2018)

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma

od Green, Damian J., Maloney, David G., Storer, Barry E., Sandmaier, Brenda M., Holmberg, Leona A., Becker, Pamela S., Fang, Min, Martin, Paul J., Georges, George E., Bouvier, Michelle E., Storb, Rainer, Mielcarek, Marco
Wydane w Blood Adv (2017)

Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate with Autologous Stem Cell Support for High-Risk Lymphoma

od Cassaday, Ryan D., Press, Oliver W., Pagel, John M., Rajendran, Joseph G., Gooley, Ted A., Fisher, Darrell R., Holmberg, Leona A., Miyaoka, Robert S., Sandmaier, Brenda M., Green, Damian J., Gopal, Ajay K.
Wydane w Clin Cancer Res (2019)

Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

od Green, Damian J., Bensinger, William I., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Pagel, John M., Frayo, Shani L., Roden, Jennifer E., Hedin, Lacey, Press, Oliver W., Gopal, Ajay K.
Wydane w Bone Marrow Transplant (2016)

Preclinical optimization of a CD20-specific chimeric antigen receptor vector and culture conditions

od Lee, Sang Yun, Olsen, Philip, Lee, Dong Hoon, Kenoyer, Aimee L., Budde, Lihua E., O’Steen, Shyril, Green, Damian J., Heimfeld, Shelly, Jensen, Michael C., Riddell, Stanley R., Press, Oliver W., Till, Brian G.
Wydane w J Immunother (2018)

Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates

od Green, Damian J., Pagel, John M., Nemecek, Eneida R., Lin, Yukang, Kenoyer, Aimee, Pantelias, Anastasia, Hamlin, Donald K., Wilbur, D. Scott, Fisher, Darrell R., Rajendran, Joseph G., Gopal, Ajay K., Park, Steven I., Press, Oliver W.
Wydane 2009

A Randomized Study of Melphalan 200 mg/m(2) vs 280 mg/m(2) as a Preparative Regimen for Patients with Multiple Myeloma Undergoing Auto-SCT

od Bensinger, William I., Becker, Pamela S., Gooley, Ted A., Chauncey, Thomas R., Maloney, David G., Gopal, Ajay K., Green, Damian J., Press, Oliver W., Lill, Michael, Ifthikharuddin, Jainulabdeen J., Vescio, Robert, Holmberg, Leona A., Phillips, Gordon L.
Wydane w Bone Marrow Transplant (2015)

Results of a Phase I-II Study of Fenretinide and Rituximab for Patients with Indolent B-Cell Lymphoma and Mantle Cell Lymphoma

od Cowan, Andrew J., Stevenson, Phillip A., Gooley, Ted A., Frayo, Shani L., Oliveira, George R., Smith, Stephen D., Green, Damian J., Roden, Jennifer E., Pagel, John M., Wood, Brent L., Press, Oliver W., Gopal, Ajay K.
Wydane w Br J Haematol (2017)